Aptevo Therapeutics Inc. ( APVO) - Key Metrics
APVO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$5.31 | -$4.56 | -$4.56 |
| 2026Q1 | $0 | -$6.31 | -$7.51 | -$7.51 |
| 2025Q4 | $0 | -$5.82 | -$5.25 | -$5.25 |
| 2025Q3 | $0 | -$33.56 | -$29.73 | -$29.73 |
| 2025Q2 | $0 | -$151.29 | -$172.97 | -$172.97 |
APVO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.21 |
| 2026Q1 | 0% | -0.17 |
| 2025Q4 | 0% | -0.01 |
| 2025Q3 | 0% | -0.16 |
| 2025Q2 | 0% | -0.09 |
APVO
Price: $2.90
52 week price:
Earnings Per Share: 1488.13 USD
P/E Ratio: 0.00
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 73389
Ebitda: -9.5 millionMarket Capitalization: 4.5 million